SN/VTA neuromelanin signal is associated with subclinical paranoia irrespective of familial risk for psychosis

Read full text
Authors: Rami Hamati, Nour Kanaa, Bianca Chidiac, Synthia Guimond, Clifford Cassidy, Lauri J. Tuominen
Cited by: 1
References: 66

Abstract

Subclinical paranoia is present in the relatives of patients with psychosis but it is also relatively common in the general population. Dopamine neurotransmission is increased in people with psychosis and is linked with positive symptoms, such as paranoia. Here, we examined if neuromelanin-sensitive MRI, a proxy of long-term dopamine turnover, is different between those with ( n = 25) and without ( n = 77) a first-degree relative with psychosis ( N = 102). We further tested whether neuromelanin-sensitive MRI was associated with the experience of subclinical paranoia as measured by the paranoia checklist. We found that there was no difference in neuromelanin-sensitive MRI signal between those with and without a first-degree relative. However, neuromelanin-sensitive MRI was significantly associated with the frequency subscore of the paranoia checklist, irrespective of familial risk (255 of 1879 voxels at p < 0.05, p corrected = 0.03). This relationship was further supported by the association of neuromelanin-sensitive MRI and community assessment of psychic experience paranoia frequency subscore (316 of 1879 voxels at p < 0.05, p corrected = 0.01). In summary, we show that subclinical paranoid thoughts are associated with a proxy of long-term dopamine turnover regardless of whether the person has a relative with psychosis or not. Thus, neuromelanin-MRI associates with positive subclinical symptomatology in those without psychotic illness, in addition to the link observed in patients.

Fields of Study & Subjects

Schizophrenia research and treatment Epilepsy research and treatment Parkinson's Disease Mechanisms and Treatments

Publication details

Journal / source
Schizophrenia
Publisher
Springer Science and Business Media LLC
Volume
12
Issue
1
Publication date
22 January 2026
Language
EN